In-frame Val216-Ser217 deletion of KIT in mild piebaldism causes aberrant secretion and SCF response.

[1]  X.-h. Xu,et al.  A novel mutation of KIT gene results in piebaldism in a Chinese family , 2016, Journal of the European Academy of Dermatology and Venereology : JEADV.

[2]  I. Betlloch,et al.  Spontaneous repigmentation in an infant with piebaldism , 2015, International journal of dermatology.

[3]  K. Kaira,et al.  An autosomal recessive mutation of DSG4 causes monilethrix through the ER stress response. , 2015, The Journal of investigative dermatology.

[4]  A. Kawada,et al.  Piebaldism , 2013, The Journal of dermatology.

[5]  E. Raglan,et al.  Homozygosity for piebaldism with a proven KIT mutation resulting in depigmentation of the skin and hair, deafness, developmental delay and autism spectrum disorder. , 2013, Clinical dysmorphology.

[6]  T. Shimizu,et al.  Repigmentation of the epidermis around the acrosyringium in piebald skin: an ultrastructural examination , 2013, The British journal of dermatology.

[7]  A. Kawada,et al.  Repigmentation of leukoderma in a piebald patient associated with a novel c-KIT gene mutation, G592E, of the tyrosine kinase domain. , 2011, Journal of dermatological science.

[8]  A. Kawada,et al.  Two children with a mild or moderate piebaldism phenotype and a father without leukoderma in a family with the same recurrent missense mutation in the kinase domain of KIT. , 2011, European journal of dermatology : EJD.

[9]  A. Utani,et al.  Familial case of piebaldism with regression of white forelock , 2008, Clinical and experimental dermatology.

[10]  Joseph Schlessinger,et al.  Structural Basis for Activation of the Receptor Tyrosine Kinase KIT by Stem Cell Factor , 2007, Cell.

[11]  V. Alexeev,et al.  Distinctive role of the cKit receptor tyrosine kinase signaling in mammalian melanocytes. , 2006, The Journal of investigative dermatology.

[12]  R. Roskoski.  Structure and regulation of Kit protein-tyrosine kinase--the stem cell factor receptor. , 2005, Biochemical and biophysical research communications.

[13]  M. Bitner-Glindzicz,et al.  Analysis of KIT, SCF, and initial screening of SLUG in patients with piebaldism. , 2005, The Journal of investigative dermatology.

[14]  L. Rönnstrand.  Signal transduction via the stem cell factor receptor/c-Kit , 2004, Cellular and Molecular Life Sciences CMLS.

[15]  A. Paller,et al.  New KIT mutations in patients with piebaldism. , 2004, Journal of dermatological science.

[16]  P. Dentelli,et al.  STAT Protein Recruitment and Activation in c-Kit Deletion Mutants* , 1999, Journal of Biological Chemistry.

[17]  T. Ishizuka,et al.  Mitogen-activated protein kinase activation through Fc epsilon receptor I and stem cell factor receptor is differentially regulated by phosphatidylinositol 3-kinase and calcineurin in mouse bone marrow-derived mast cells. , 1999, Journal of immunology.

[18]  T. Ishizuka,et al.  Mitogen-activated protein kinase activation through Fc epsilon receptor I and stem cell factor receptor is differentially regulated by phosphatidylinositol 3-kinase and calcineurin in mouse bone marrow-derived mast cells. , 1999, Journal of immunology.

[19]  P. Besmer,et al.  Kit signaling through PI 3‐kinase and Src kinase pathways: an essential role for Rac1 and JNK activation in mast cell proliferation , 1998, The EMBO journal.

[20]  S. Nishikawa,et al.  Transgene expression of steel factor in the basal layer of epidermis promotes survival, proliferation, differentiation and migration of melanocyte precursors. , 1998, Development.

[21]  K D Wittrup,et al.  Protein Folding Stability Can Determine the Efficiency of Escape from Endoplasmic Reticulum Quality Control* , 1998, The Journal of Biological Chemistry.

[22]  C. Deberry,et al.  Lyn Associates with the Juxtamembrane Region of c-Kit and Is Activated by Stem Cell Factor in Hematopoietic Cell Lines and Normal Progenitor Cells* , 1997, The Journal of Biological Chemistry.

[23]  C. Deberry,et al.  Stat1 associates with c-kit and is activated in response to stem cell factor. , 1997, The Biochemical journal.

[24]  N. S. Yee,et al.  Differential roles of PI3‐kinase and Kit tyrosine 821 in Kit receptor‐mediated proliferation, survival and cell adhesion in mast cells. , 1995, The EMBO journal.

[25]  H. Serve,et al.  Tyrosine residue 719 of the c-kit receptor is essential for binding of the P85 subunit of phosphatidylinositol (PI) 3-kinase and for c-kit-associated PI 3-kinase activity in COS-1 cells. , 1994, The Journal of biological chemistry.

[26]  R. Spritz,et al.  Dominant negative and loss of function mutations of the c-kit (mast/stem cell growth factor receptor) proto-oncogene in human piebaldism. , 1992, American journal of human genetics.

[27]  R. Spritz,et al.  Mutation of the KIT (mast/stem cell growth factor receptor) protooncogene in human piebaldism. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[28]  M. Ishii,et al.  Acquired pigmented macules in human piebald lesions. Ultrastructure of melanocytes in hypomelanotic skin. , 1989, Acta Dermato-Venereologica.

[29]  Y. Mishima,et al.  Tyrosinase-positive melanocyte distribution and induction of pigmentation in human piebald skin. , 1988, Archives of dermatology.

[30]  M. Hultén,et al.  Homozygosity in piebald trait. , 1987, Journal of Medical Genetics.